Debt Capital Markets

Targeted solutions, powerful distribution.

The Raymond James Debt Capital Markets team works closely with issuers across all sectors, including first-time issuers and those with complex situations, to raise public debt capital for our clients. Our origination capabilities span investment grade, high yield and structured products.  We oversee identifying the proper deal structure, offering format and marketing strategy to optimize deal execution. Raymond James has one of the largest institutional sales forces in the United States, with over 200 professionals located throughout the country. This enables us to reach a significantly larger number of institutional investors when marketing new-issue transactions, including many small- and mid-sized investors often overlooked by larger firms.

Debt Capital Markets Expertise

  • Investment Grade Debt
  • High Yield Debt
  • Structured Debt

Senior Banking Team

Julian Bynum
Managing Director, Head of Debt Capital Markets
New York
   
Read Bio
Bio-no-photo
David Barcus
Managing Director, Head of High Yield Capital Markets
New York
   
Grant Dabbelt
Managing Director
New York
   
Read Bio

Transaction History

Transaction history may include a transaction completed by a Raymond James banker while at a former firm.

Industry Insight

To select your areas of interest and begin receiving our insights and other updates, click sign up below.

Recent News

Investment Banking  |  August 15, 2023

Raymond James hires two senior bankers to Healthcare investment banking practice

Read more about Raymond James hires two senior bankers to Healthcare investment banking practice
Investment Banking  |  July 10, 2023

Raymond James hires veteran senior medical technology banker, continuing Healthcare Investment Banking practice momentum

Read more about Raymond James hires veteran senior medical technology banker, continuing Healthcare Investment Banking practice momentum
Equity Research  |  June 15, 2023

Raymond James hires Gary Nachman as senior life sciences analyst

Read more about Raymond James hires Gary Nachman as senior life sciences analyst